Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status

Ionizing radiation triggers diverse responses in human cells encompassing apoptosis, necrosis, stress-induced premature senescence (SIPS), autophagy, and endopolyploidy (e.g., multinucleation). Most of these responses result in loss of colony-forming ability in the clonogenic survival assay. However, not all modes of so-called clonogenic cell “death” are necessarily advantageous for therapeutic outcome in cancer radiotherapy. For example, the crosstalk between SIPS and autophagy is considered to influence the capacity of the tumor cells to maintain a prolonged state of growth inhibition that unfortunately can be succeeded by tumor regrowth and disease recurrence. Likewise, endopolyploid giant cells are able to segregate into near diploid descendants that continue mitotic activities. Herein we review the current knowledge on the roles that the p53 and p21WAF1 tumor suppressors play in determining the fate of human fibroblasts (normal and Li-Fraumeni syndrome) and solid tumor-derived cells after exposure to ionizing radiation. In addition, we discuss the important role of WIP1, a p53-regulated oncogene, in the temporal regulation of the DNA damage response and its contribution to p53 dynamics post-irradiation. This article highlights the complexity of the DNA damage response and provides an impetus for rethinking the nature of cancer cell resistance to therapeutic agents.

[1]  I. Roninson,et al.  p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation , 2007, Oncogene.

[2]  E. Wang,et al.  Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. , 1995, Cancer research.

[3]  M. Lohrum,et al.  Regulation and activation of p53 and its family members , 1999, Cell Death and Differentiation.

[4]  C. Norbury,et al.  Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. , 1995, Trends in biochemical sciences.

[5]  B. McKay,et al.  P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts , 2001, Oncogene.

[6]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[7]  A. Levine,et al.  The P53 pathway: what questions remain to be explored? , 2006, Cell Death and Differentiation.

[8]  Z. Cheng,et al.  Cell fate decision mediated by p53 pulses , 2009, Proceedings of the National Academy of Sciences.

[9]  A. Heijink,et al.  The DNA damage response during mitosis. , 2013, Mutation research.

[10]  R. Sabin,et al.  Cellular Senescence - its role in cancer and the response to ionizing radiation , 2011, Genome Integrity.

[11]  G. Wahl,et al.  p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. , 1997, Cancer research.

[12]  D. Stoppa-Lyonnet,et al.  Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. , 1996, Cancer research.

[13]  A. Fornace,et al.  Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. , 2010, Cancer research.

[14]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[15]  L. Galluzzi,et al.  Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos , 2010, The EMBO journal.

[16]  F. Besançon,et al.  Inactivation of p21 WAF1 Sensitizes Cells to Apoptosis via an Increase of Both p14ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio* , 2002, The Journal of Biological Chemistry.

[17]  G. Kroemer,et al.  Apoptosis and genomic instability , 2004, Nature Reviews Molecular Cell Biology.

[18]  E. Kandel,et al.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. , 1999, Cancer research.

[19]  G. Wahl,et al.  p53 Mediates Permanent Arrest over Multiple Cell Cycles in Response to γ-Irradiation , 1997 .

[20]  Akira Nakagawara,et al.  PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.

[21]  D. Guernsey,et al.  Neosis—a paradigm of self‐renewal in cancer , 2005, Cell biology international.

[22]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[23]  K. Schulze-Osthoff,et al.  p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation. , 2006, Cancer research.

[24]  R. Mirzayans,et al.  Relationship between the radiosensitizing effect of wortmannin, DNA double‐strand break rejoining, and p21WAF1 induction in human normal and tumor‐derived cells , 2004, Molecular carcinogenesis.

[25]  A. Gartel,et al.  The Role of the Cyclin-dependent Kinase Inhibitor p 21 in Apoptosis 1 , 2002 .

[26]  Mansoor M Ahmed,et al.  Enhancement of Gamma Radiation-induced Cytotoxicity of Breast Cancer Cells by Curcumin , 2009 .

[27]  P. Hanawalt,et al.  Transcription-coupled DNA repair: two decades of progress and surprises , 2008, Nature Reviews Molecular Cell Biology.

[28]  D. Kozono,et al.  Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. , 2011, Surgery.

[29]  P. Hanawalt,et al.  Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[31]  R. Mirzayans,et al.  Single‐cell analysis of p16INK4a and p21WAF1 expression suggests distinct mechanisms of senescence in normal human and Li‐Fraumeni Syndrome fibroblasts , 2009, Journal of cellular physiology.

[32]  R. Mirzayans,et al.  Role of p16INK4A in Replicative Senescence and DNA Damage-Induced Premature Senescence in p53-Deficient Human Cells , 2012, Biochemistry research international.

[33]  R. Medema,et al.  Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition , 2010, Oncogene.

[34]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[35]  Michael Berger,et al.  Apoptosis - the p53 network , 2003, Journal of Cell Science.

[36]  Zhi-Min Yuan,et al.  MDM2 and MDMX: Alone and together in regulation of p53. , 2012, Translational cancer research.

[37]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[38]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[39]  B. McKay,et al.  Role for p53 in the recovery of transcription and protection against apoptosis induced by ultraviolet light. , 1999, Neoplasia.

[40]  Manuel Serrano,et al.  p53: Guardian of the Genome and Policeman of the Oncogenes , 2007, Cell cycle.

[41]  W. Taylor,et al.  CARBENOXOLONE AND GASTRIC SECRETION , 1975, The Lancet.

[42]  D. Gewirtz Autophagy, senescence and tumor dormancy in cancer therapy , 2009, Autophagy.

[43]  M. Kalējs,et al.  Activation of meiosis-specific genes is associated with depolyploidization of human tumor cells following radiation-induced mitotic catastrophe. , 2009, Cancer research.

[44]  S. Clarkson,et al.  Suppression of UV-induced apoptosis by the human DNA repair protein XPG , 2006, Cell Death and Differentiation.

[45]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.

[46]  A. Levine,et al.  The p53 functional circuit. , 2001, Journal of cell science.

[47]  M. Savio,et al.  p21waf1/cip1-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites , 2001, Oncogene.

[48]  E. Appella,et al.  Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.

[49]  G. Wahl,et al.  The p53 orchestra: Mdm2 and Mdmx set the tone. , 2010, Trends in cell biology.

[50]  J. Boyle,et al.  Cell cycle arrest defect in Li – Fraumeni Syndrome: a mechanism of cancer predisposition? , 1997, Oncogene.

[51]  N. Lakin,et al.  The p53-mediated DNA damage response to ionizing radiation in fibroblasts from ataxia-without-telangiectasia patients. , 1998, International journal of radiation biology.

[52]  M. Protopopova,et al.  Dose – response for radiation-induced apoptosis, residual 53BP1 foci and DNA-loop relaxation in human lymphocytes , 2005, International journal of radiation biology.

[53]  M. Evans,et al.  p53 modulation of TFIIH–associated nucleotide excision repair activity , 1995, Nature Genetics.

[54]  D. Guernsey,et al.  Neosis: A Novel Type of Cell Division in Cancer , 2004, Cancer biology & therapy.

[55]  Y. Liou,et al.  Dose-dependent mutual regulation between Wip1 and p53 following UVC irradiation. , 2011, The international journal of biochemistry & cell biology.

[56]  R. Mirzayans,et al.  New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy , 2012, Journal of biomedicine & biotechnology.

[57]  T. Hupp,et al.  p21WAF1 is component of a positive feedback loop that maintains the p53 transcriptional program , 2011, Cell cycle.

[58]  G. Lahav,et al.  Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. , 2008, Molecular cell.

[59]  J. Yahalom,et al.  Pathways that Regulate Autophagy and their Role in Mediating Tumor Response to Treatment , 2006, Autophagy.

[60]  M. Oren,et al.  The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.

[61]  J. Fraumeni,et al.  TRANSMISSION OF IN-VITRO RADIORESISTANCE IN A CANCER-PRONE FAMILY , 1981, The Lancet.

[62]  Xiongbin Lu,et al.  Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response. , 2009, Cancer research.

[63]  R. Mirzayans,et al.  Faculty DNA polymerase δ/ɛ-mediated excision repair in response to γ radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome , 1996 .

[64]  G. Parris Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species. , 2005, Medical hypotheses.

[65]  F. Choy,et al.  p53-based anti-cancer therapies: An empty promise? , 2010, Current issues in molecular biology.

[66]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[67]  I. Roninson Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.

[68]  David J. Chen,et al.  Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. , 2005, Cancer research.

[69]  K Watanabe,et al.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[71]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[72]  R. Honda,et al.  Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 , 1999, The EMBO journal.

[73]  R. Mirzayans,et al.  Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li–Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations , 1998, Oncogene.

[74]  M. Cuadrado,et al.  ATM regulates ATR chromatin loading in response to DNA double-strand breaks , 2006, The Journal of experimental medicine.

[75]  Masaaki Adachi,et al.  p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.

[76]  I. Roninson,et al.  p21 (CDKN1A) is a Negative Regulator of p53 Stability , 2007, Cell cycle.

[77]  Kirsten H Walen,et al.  Budded karyoplasts from multinucleated fibroblast cells contain centrosomes and change their morphology to mitotic cells , 2005, Cell biology international.

[78]  D. Brash,et al.  Progressive apoptosis resistance prior to senescence and control by the anti-apoptotic protein BCL-xL , 2008, Mechanisms of Ageing and Development.

[79]  A. Magalska,et al.  Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells , 2009, Mechanisms of Ageing and Development.

[80]  R. Tjian,et al.  Repression of p53-mediated transcription by MDM2: a dual mechanism. , 1997, Genes & development.

[81]  K. Walen Spontaneous cell transformation: Karyoplasts derived from multinucleated cells produce new cell growth in senescent human epithelial cell cultures , 2004, In Vitro Cellular & Developmental Biology - Animal.

[82]  Wei Wang,et al.  Two-phase dynamics of p53 in the DNA damage response , 2011, Proceedings of the National Academy of Sciences.

[83]  J. Settleman,et al.  EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks. , 2011, Cancer research.

[84]  B. McKay,et al.  The anti-apoptotic role for p53 following exposure to ultraviolet light does not involve DDB2. , 2009, Mutation research.

[85]  Keiji Suzuki,et al.  Radiation-Induced Senescence-like Growth Arrest Requires TP53 Function but not Telomere Shortening , 2001, Radiation research.

[86]  R. Mirzayans,et al.  Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity. , 2006, International journal of radiation oncology, biology, physics.

[87]  Ruedi Aebersold,et al.  Beyond ATM: The protein kinase landscape of the DNA damage response , 2011, FEBS letters.

[88]  M. Cragg,et al.  Cancer: A matter of life cycle? , 2007, Cell biology international.

[89]  M. Lavin,et al.  ATM Activation and DNA Damage Response , 2007, Cell cycle.

[90]  R. Mirzayans,et al.  Radiosensitivity in ataxia telangiectasia fibroblasts is not associated with deregulated apoptosis. , 1998, Radiation research.

[91]  Y. Shiloh,et al.  Programs for Cell Death: Apoptosis is Only One Way to Go , 2007, Cell cycle.

[92]  R. Mirzayans,et al.  Induction of Accelerated Senescence by γ Radiation in Human Solid Tumor-Derived Cell Lines Expressing Wild-Type TP53 , 2005, Radiation research.

[93]  S. -. Park,et al.  Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts , 2007, Cell Death and Differentiation.

[94]  Yves Pommier,et al.  γH2AX and cancer , 2008, Nature Reviews Cancer.

[95]  M. Wani,et al.  Human cells deficient in p53 regulated p21(waf1/cip1) expression exhibit normal nucleotide excision repair of UV-induced DNA damage. , 2002, Carcinogenesis.

[96]  C. Telleria Repopulation of Ovarian Cancer Cells After Chemotherapy , 2013, Cancer growth and metastasis.

[97]  M. Cragg,et al.  Macroautophagy-aided elimination of chromatin , 2012, Autophagy.

[98]  I. Tannock,et al.  Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[99]  Y. Shiloh,et al.  ATM-Mediated Phosphorylations Inhibit Mdmx/Mdm2 Stabilization by HAUSP in Favor of p53 Activation , 2005, Cell cycle.

[100]  I. Roninson,et al.  Tumor cell senescence in cancer treatment. , 2003, Cancer research.

[101]  W. El-Deiry,et al.  p21WAF1 and tumourigenesis: 20 years after , 2013, Current opinion in oncology.

[102]  H. Viadiu Molecular architecture of tumor suppressor p53. , 2008, Current topics in medicinal chemistry.

[103]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[104]  A. Aboussekhra,et al.  ATR controls the p21WAF1/Cip1 protein up‐regulation and apoptosis in response to low UV fluences , 2012, Molecular carcinogenesis.

[105]  G. Wahl,et al.  MDM2 and MDM4: p53 regulators as targets in anticancer therapy. , 2007, The international journal of biochemistry & cell biology.

[106]  Jean Y. J. Wang,et al.  Coordination of repair, checkpoint, and cell death responses to DNA damage. , 2004, Advances in protein chemistry.

[107]  Yolanda F. Darlington,et al.  Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant γ-H2AX and Suppresses DNA Double Strand Break Repair* , 2010, The Journal of Biological Chemistry.

[108]  C. Harris,et al.  p53: traffic cop at the crossroads of DNA repair and recombination , 2005, Nature Reviews Molecular Cell Biology.

[109]  J. Varley,et al.  Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations , 1999, British Journal of Cancer.

[110]  I. Tannock,et al.  Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts. , 2005, Cancer research.

[111]  R. Weiss p21Waf1/Cip1 as a therapeutic target in breast and other cancers. , 2003, Cancer cell.

[112]  Xiongbin Lu,et al.  The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.

[113]  Jeffrey R. Marks,et al.  Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.

[114]  J Wade Harper,et al.  The DNA damage response: ten years after. , 2007, Molecular cell.

[115]  E. Crescenzi,et al.  Ataxia Telangiectasia Mutated and p21CIP1 Modulate Cell Survival of Drug-Induced Senescent Tumor Cells: Implications for Chemotherapy , 2008, Clinical Cancer Research.

[116]  L. Donehower,et al.  PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. , 2005, Genes & development.

[117]  Yumin Li,et al.  Molecular Machinery of Autophagy and Its Implication in Cancer , 2012, The American journal of the medical sciences.

[118]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[119]  Michel Nussenzweig,et al.  H2AX: the histone guardian of the genome. , 2004, DNA repair.

[120]  T. Hofmann,et al.  Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. , 2007, Cancer research.

[121]  Wei Wang,et al.  Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage* , 2010, The Journal of Biological Chemistry.

[122]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[123]  N. Lakin,et al.  Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex , 2006, Oncogene.

[124]  Y. Taya,et al.  A Role for the p38 Mitogen-activated Protein Kinase Pathway in the Transcriptional Activation of p53 on Genotoxic Stress by Chemotherapeutic Agents , 2000 .

[125]  J. Vávrová,et al.  The importance of senescence in ionizing radiation-induced tumour suppression. , 2011, Folia biologica.

[126]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[127]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[128]  N. Onishi,et al.  Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase , 2006, Cell Death and Differentiation.

[129]  Yolanda F. Darlington,et al.  The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways , 2008, Cancer and Metastasis Reviews.

[130]  G. Dotto,et al.  p21(WAF1/Cip1): more than a break to the cell cycle? , 2000, Biochimica et biophysica acta.

[131]  A. Snow,et al.  Mechanisms of Radiation Toxicity in Transformed and Non-Transformed Cells , 2013, International journal of molecular sciences.

[132]  P. Hasty,et al.  p53 as an intervention target for cancer and aging , 2013, Pathobiology of aging & age related diseases.

[133]  U. Moll,et al.  In Vivo Mitochondrial p53 Translocation Triggers a Rapid First Wave of Cell Death in Response to DNA Damage That Can Precede p53 Target Gene Activation , 2004, Molecular and Cellular Biology.

[134]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[135]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.

[136]  Paul Brazhnik,et al.  Exploring Mechanisms of the DNA-Damage Response: p53 Pulses and their Possible Relevance to Apoptosis , 2007, Cell cycle.

[137]  I. H. Engels,et al.  Apoptosis Resistance of MCF-7 Breast Carcinoma Cells to Ionizing Radiation Is Independent of p53 and Cell Cycle Control but Caused by the Lack of Caspase-3 and a Caffeine-Inhibitable Event , 2004, Cancer Research.

[138]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[139]  Peter Jackson,et al.  The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. , 2000, Trends in cell biology.

[140]  D. Guernsey,et al.  Stem cells, senescence, neosis and self-renewal in cancer , 2006, Cancer Cell International.

[141]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[142]  A. Thor,et al.  Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. , 2001, Cancer research.

[143]  Weiya Ma,et al.  p38 Kinase Mediates UV-induced Phosphorylation of p53 Protein at Serine 389* , 1999, The Journal of Biological Chemistry.

[144]  U. Knippschild,et al.  p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. , 1996, The EMBO journal.

[145]  J. Marine,et al.  Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.

[146]  R. Margolis,et al.  Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. , 2001, Cancer research.

[147]  R. Jänicke MCF-7 breast carcinoma cells do not express caspase-3 , 2009, Breast Cancer Research and Treatment.

[148]  D. Gewirtz Cytoprotective and nonprotective autophagy in cancer therapy , 2013, Autophagy.

[149]  M. Cragg,et al.  MOS, aneuploidy and the ploidy cycle of cancer cells , 2010, Oncogene.

[150]  L. Elmore,et al.  p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells , 2005, International journal of radiation biology.

[151]  A. Taylor,et al.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity , 1975, Nature.

[152]  J. McCubrey,et al.  Neosis and its Potential Role in Cancer Development and Chemoresistance , 2004, Cancer biology & therapy.

[153]  J. Hoeijmakers,et al.  Nucleotide excision repair and human syndromes. , 2000, Carcinogenesis.

[154]  Jae-Seon Lee,et al.  Time-dependently expressed markers and the characterization for premature senescence induced by ionizing radiation in MCF7. , 2010, Oncology reports.

[155]  M. Olivier,et al.  Relaxed cell‐cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild‐type p53 , 1998, Molecular carcinogenesis.

[156]  Jun Li,et al.  A Two-Step Mechanism for Cell Fate Decision by Coordination of Nuclear and Mitochondrial p53 Activities , 2012, PloS one.

[157]  R. Mirzayans,et al.  Ultraviolet light exposure triggers nuclear accumulation of p21WAF1 and accelerated senescence in human normal and nucleotide excision repair‐deficient fibroblast strains , 2008, Journal of cellular physiology.

[158]  Jeremy E. Purvis,et al.  p53 Dynamics Control Cell Fate , 2012, Science.

[159]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[160]  M. Cragg,et al.  Polyploid tumour cells elicit paradiploid progeny through depolyploidizing divisions and regulated autophagic degradation , 2011, Cell biology international.

[161]  Y. Shiloh,et al.  ATM: from gene to function. , 1998, Human molecular genetics.

[162]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[163]  R. Slebos,et al.  Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. , 1993, Cancer research.

[164]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[165]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[166]  W. Blattner,et al.  Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. , 1995, British Journal of Cancer.